Bionano Genomics, Inc. (BNGO) News
Track canonical SquawkNews coverage tagged to BNGO, Bionano Genomics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
Bionano Genomics Stock Surges Tuesday: What's Going On?
Shares of Bionano Genomics Inc. (NASDAQ: BNGO ) are trading sharply higher Tuesday afternoon, expanding multi-session upside as investors digest management’s multi-year growth strategy delivered at a major healthcare con
LIVE | Sep 15, 2026, 07:12 PM UTC
M
Bionano reports Q2 revenue, raises guidance
Bionano Genomics said Q2 2026 revenue was $8.2 million, raised FY26 guidance and gave a FY27 revenue target. It also projected EBITDA break-even in Q4 FY27.
EQUITY | Sep 14, 2026, 12:33 PM UTC
L
Bionano to participate in H.C. Wainwright conference
Bionano said it will participate in the H.C. Wainwright 28th Annual Global Investment Conference.
REGULATION | Aug 24, 2026, 12:00 PM UTC
L
Bionano Genomics Raises FY2026 Sales Guidance from $30.000M-$33.000M to $31.000M-$33.000M vs $32.137M Est
Bionano Genomics (NASDAQ: BNGO ) raises FY2026 sales outlook from $30.000 million-$33.000 million to $31.000 million-$33.000 million vs $32.137 million estimate.
EARNINGS | Aug 10, 2026, 08:07 PM UTC